[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Arvinas, Inc (ARVN)
Arvinas presents promising preclinical data for ARV-393 in lymphoma models, showing significant tumor growth inhibition when combined with glofitamab. Phase X combination cohort planned for 2026.
About Arvinas, Inc
Arvinas, Inc. is a biotechnology company focused on developing protein degraders for various diseases, particularly in oncology.
Arvinas, Inc uses the ticker $ARVN for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Arvinas, Inc (ARVN) trading volume is up XXXXX% from the previous week.
Price: $XXXXX
Price 24-Hour Time-Series Raw Data
The stock is experiencing downward pressure due to analyst downgrades and market volatility, despite positive preclinical data and upcoming catalysts that create mixed social sentiment.
24-Hour: XXXX% 7-Day: -XXXX% 30-Day: XXXXX%
1-Year High: $XXXXX on 2025-01-03
1-Year Low: $XXXX on 2025-05-14
AltRank: XXXXX
AltRank 24-Hour Time-Series Raw Data
Arvinas, Inc (ARVN) is currently AltRank #1,459 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXXXX +320
X Month: XXXXX +113
X Months: XXXXX +80
X Year: XXXXX +1,076
1-Year High: XXXXX on 2025-09-04
1-Year Low: XX on 2025-01-18
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -XX
X Months: XX +11
X Year: XX -XX
1-Year High: XX on 2025-07-21
1-Year Low: XX on 2025-09-25
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXX -XX%
X Month: XXXXXXX +197%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXX +97%
1-Year High: XXXXXXX on 2025-02-11
1-Year Low: XXX on 2025-11-02
Engagements by network (24h): Reddit: XX X: XXXXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX -XX%
X Month: XXXXX +408%
X Months: XXXXX +54%
X Year: XXXXX +234%
1-Year High: XXX on 2025-11-21
1-Year Low: XX on 2025-09-15
Mentions by network (24h): Reddit: X X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Arvinas, Inc (ARVN) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XXX -XX%
X Month: XXXXX +715%
X Months: XXXXX +275%
X Year: XXXXX +339%
1-Year High: XXX on 2025-06-29
1-Year Low: X on 2025-01-27
The most influential creators that mention Arvinas, Inc in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @aditharun_ | X | XXXXX | X | XXX |
| @financebully | X | XXX | X | XXX |
| @BuyTheUgly | X | XX | X | XXX |
| @Banana_Oncology | X | XXXXX | X | XX |
| @ParadiseTraderr | X | XXX | X | XX |
| @mariostario2019 | X | XX | X | XX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2025-08-15
1-Year Low: XX% on 2025-09-21
Most Supportive Themes:
- Positive Analyst Ratings and Partnerships: (25%) Mentions of partnerships and positive analyst ratings, such as the one from Bank of America, are seen as supportive.
- Upcoming Catalysts and Data Releases: (20%) The anticipation surrounding the ASCO presentation and regulatory filings for ARV-471 is a supportive theme.
Most Critical Themes:
- Analyst Downgrades: (15%) Downgrades from Truist and BMO are viewed as critical.
- Market Volatility: (10%) The stock's price fluctuations and negative 7-day performance are critical.
Social Dominance: XXXXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
X Week: XXXXXX% -XXXXXX%
X Month: XXXXX% +0.0005000000000000004%
X Months: XXXXX% -XXXXXX%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2024-12-26
1-Year Low: XXXXXX% on 2025-10-12
Market Dominance: XXXXXXXXXXXXXXXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXXXXXXXXXXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-10
1-Year Low: XXXXXXX% on 2025-12-11
Market Cap: $XXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXX
Daily Average: $XXXXXXXXXXX
X Week: $XXXXXXXXXXX +$0.16%
X Month: $XXXXXXXXXXX +$12%
X Months: $XXXXXXXXXXX +$50%
X Year: $XXXXXXXXXXX -$48%
1-Year High: $XXXXXXXXXXXXX on 2025-01-03
1-Year Low: $XXXXXXXXXXX on 2025-04-08
Top Arvinas, Inc Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Is $ARVN's vepdegestrant not very attractive It has an NDA pending for ESR1m ER+/HER2- advanced breast cancer. Has $788m of cash and EV of $55m Doesn't make sense. $ARVN mgmt needs to sell the whole company and spin back out PROTAC programs"
X Link @AppleHelix 2025-12-11T16:24Z 10.4K followers, 2515 engagements
"@DrRishabhOnco @OncoAlert @Larvol thanks but this isn't completely accurate. X. SERDs induce ER conformational change that leads to degradation. X. $olma states that palazestrant acts as both a CERAN and SERD. $arvn"
X Link @financebully 2025-12-10T22:56Z XXX followers, XXX engagements
"@aditharun_ @bingbingbom $ARVN $GUTS $PMVP all interesting IMO (though pretty different setups)"
X Link @pemulisking 2025-12-10T17:35Z XXX followers, XXX engagements
"$arvn - protac company w X program waiting for partner and other protac/riptac companies surging $guts - many opinions from vulpes and others but small mc and interesting q1 readout pending $tenx - small but interesting player in ph space w goss tecx azn mrk and others $pmvp - what do u think about reactivator p53 molecules and management is what the question boils down to $xlo - warrants and interesting biology: masked tce"
X Link @aditharun_ 2025-12-10T17:32Z 1265 followers, XXX engagements